[1].活化的T细胞核因子在新疆哈萨克族不同级别高血压患者中的表达[J].心血管病学进展,2020,(11):1203-1208.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
　MENG Xiaopan,TAN Meng,DONG Jian,et al.Expression of N uclear Factor of Activated T Cells in Patients with Different Grades of Hypertension in Xinjiang Kazakh Nationality[J].Advances in Cardiovascular Diseases,2020,(11):1203-1208.[doi:10.16806/j.cnki.issn.1004-3934.2020.11.000]
点击复制

活化的T细胞核因子在新疆哈萨克族不同级别高血压患者中的表达()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年11期
页码:
1203-1208
栏目:
论著
出版日期:
2020-11-25

文章信息/Info

Title:
Expression of N uclear Factor of Activated T Cells in Patients with Different Grades of Hypertension in Xinjiang Kazakh Nationality
文章编号:
202005086
作者:
?新疆医科大学第一附属医院心脏中心,新疆 乌鲁木齐 830000)
Author(s):
MENG Xiaopan; TAN Meng; DONG Jian; DAI Chen; ZHANG Yuanming
(Heart Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, Xinjiang, China)
关键词:
高血压; T淋巴细胞; 活化的T细胞核因子
Keywords:
Hypertension; T lymphocytes; Nuclear factor of activated T cells
DOI:
10.16806/j.cnki.issn.1004-3934.2020.11.000
摘要:
目的 研究活化的T细胞核因子（NFAT）及其相关分子在新疆哈萨克族不同级别高血压患者外周血T淋巴细胞中的表达水平变化。方法 选取就诊于新疆医科大学第一附属医院高血压病房未经药物干预的新疆哈萨克族高血压1级组、2级组和3级组为实验组，血压正常的哈萨克族健康者为对照组，各30例，各组男女比例相等。运用RT-qPCR技术和Western blotting技术分别检测外周血T淋巴细胞NFAT、白介素-17基因和NFAT蛋白表达。结果 与对照组相比，高血压3级组、2级组和1级组的NFAT mRNA和蛋白以及白介素-17 mRNA相对表达量明显增加（P＜0.05）。NFAT mRNA表达水平与高血压2级组和高血压3级组均存在正相关关系（P＜0.01）；NFAT蛋白和白介素-17 mRNA表达水平与3个不同级别高血压组均存在正相关关系（P＜0.05）。结论 活化的T细胞核因子在新疆哈萨克族不同级别高血压患者外周血T淋巴细胞上的表达随血压水平的升高而增加并呈正相关关系。
Abstract:
Objective To study the expression level of nuclear factor of activated T cells （NFAT） and its related molecules in T lymphocytes of peripheral blood from patients with different grade s of hypertension in Xinjiang Kazakh nationality. Methods The Kazak h patients hospitalized in hypertensive ward of The First Affiliated Hospital of Xinjiang Medical University with grade 1, grade 2 and grade 3 hypertension without drug intervention were selected as experimental group, and the Kazakh healthy people with normal blood pressure as control group . 30 cases with same proportion of gender were divided into each group. RT-qPCR and Western blotting were used to detect the expression of NFAT, IL-17 gene and NFAT protein in T cells, respectively. Results The relative expression of NFAT mRNA, protein and IL-17 mRNA in grade 3, grade 2 and grade 1 hypertension group was significantly increased compared with control group（P＜0.05）. The expression of NFAT mRNA was positively correlated with grade 2 and grade 3 hypertension group （P＜0.01）. The expression levels of NFAT protein and IL-17 mRNA w ere both positively correlated with three grade hypertension groups （P＜0.05）. Conclusion The expression of NFAT in T lymphocytes of peripheral blood from Xinjiang Kazakh patients with different grades of hypertension was increased and positively correlated with elevated blood pressure.

参考文献/References:

[1]Drummond GR,Vinh A,Guzik TJ,et al. Immune mechanisms of hypertension[J]. Nat Rev Immunol,2019,19(8):517-532.

[2]季也,蔡虎志,陈青扬,等. 炎性细胞因子与原发性高血压发病机制关系的探究[J]. 中西医结合心脑血管病杂志,2017,15(21):2712-2715.

[3] Moshfegh CM,Case AJ. The redox-metabolic couple of T lymphocytes: potential consequences for hypertension[J]. Antioxid Redox Signal, 2020,10,1089/ars.2020.8042. DOI:10.1089/ars.2020.8042

[4]Ren J,Crowley SD. Role of T-cell activation in salt-sensitive hypertension[J]. Am J Physiol Heart Circ Physiol,2019,316(6):H1345-H1353.

[5]Carnagarin R,Matthews V,Zaldivia MTK,et al. The bidirectional interaction between the sympathetic nervous system and immune mechanisms in the pathogenesis of hypertension[J]. Br J Pharmacol,2019,176(12):1839-1852.

[6]Huang SS,He SL,Zhang YM. The effects of telmisartan on the nuclear factor of activated T lymphocytes signalling pathway in hypertensive patients[J]. J Renin Angiotensin Aldosterone Syst,2016,17(2):1470320316655005.

[7]贺思利,张源明,黄莎莎,等. 活化的T细胞核因子信号通路在新疆哈萨克族高血压患者中的表达及其药物干预的试验研究[J]. 中华临床医师杂志(电子版),2016,10(7):913-918.

[8]G?tz MR,Collado JA,Fernández-Ruiz J,et al. Structure-effect relationships of novel semi-synthetic cannabinoid derivatives[J]. Front Pharmacol,2019,10:1284.

[9]中国高血压防治指南修订委员会,高血压联盟,中华医学会心血管病学分会中国医师协会高血压专业委员会,等. 中国高血压防治指南(2018年修订版)[J].中国心血管杂志,2019,24(1):24-56.

[10]Wen Y,Crowley SD. Renal effects of cytokines in hypertension[J]. Adv Exp Med Biol, 2019,1165:443-454.

[11]马建华. 高血压患者动态血压相关指数与患者血清中C反应蛋白和IL-17水平的关系[J]. 中西医结合心血管病电子杂志,2018,6(14):50-51.

[12] Zhao ZG,Wang HF,Wang YW,et al. The mechanisms of AngⅡ-induced hypertensive vascular remodeling under suppression of CD68 in macrophages[J]. Eur R ev Med Pharmacol Sci,2018,22(18):6093-6099.

[13]Rucker AJ,Rudemiller NP,Crowley SD. Salt,hypertension,and immunity[J]. Annu Rev Physiol,2018,80(1):283-307.

[14]Lu X,Crowley SD. Inflammation in salt-sensitive hypertension and renal damage[J]. Curr Hypertens Rep,2018,20(12):103.

[15]范婷婷,何非,王晓晨. IL-6、IL-17、TGF-β1与高血压模型大鼠肾纤维化的相关性[J]. 中国医学前沿杂志(电子版),2019,11(7):96-99.

[16]Lozano T,Villanueva L,Durántez M,et al. Inhibition of FOXP3/NFAT interaction enhances T cell function after TCR stimulation[J]. J Immunol,2015,195(7):3180-3189.

[17]Chen R,Yan J,Liu P,et al. The role of nuclear factor of activated T cells in pulmonary arterial hypertension[J]. Cell Cycle,2017,16(6):508-514.

[18]Vaeth M,Feske S. NFAT control of immune function:New Frontiers for an Abiding Trooper[J]. F1000Res,2018,7:260.

[19]Xu XP,Yao YM,Zhao GJ,et al. Role of the Ca2+-calcineurin-nuclear factor of activated T cell pathway in mitofusin-2-mediated immune function of Jurkat cells[J]. Chin Med J (Engl),2018,131(3):330-338.

[20]Wenzel UO,Bode M,Kurts C,et al. Salt,inflammation,IL-17 and hypertension[J]. Br J Pharmacol,2019,176(12):1853-1863.

[21]Ghosh S,Koralov SB,Stevanovic I,et al. Hyperactivation of nuclear factor of activated T cells 1(NFAT1) in T cells attenuates severity of murine autoimmune encephalomyelitis[J]. Proc Natl Acad Sci U S A,2010,107(34):15169-15174.

[22]Reppert S,Zinser E,Holzinger C,et al. NFATc1 deficiency in T cells protects mice from experimental autoimmune encephalomyelitis[J]. Eur J Immunol,2015,45(5):1426-1440.

[23]Baur J,Otto C,Steger U,et al. The transcription factor NFATc1 supports the rejection of heterotopic heart allografts[J]. Front Immunol,2018,9:1338.

相似文献/References:

[1]孙刚,黄冠华,综述.高血压合并心力衰竭的治疗策略[J].心血管病学进展,2016,(2):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
　SUN Gang,HUANG Guanhua.Treatment Strategy of Hypertension with Heart Failure[J].Advances in Cardiovascular Diseases,2016,(11):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
[2]范贵娟,综述,徐瑞,等.盐敏感性高血压的研究进展[J].心血管病学进展,2016,(4):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
　FAN Guijuan,XU Rui.Research Progress of Salt Sensitive Hypertension[J].Advances in Cardiovascular Diseases,2016,(11):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
[3]陈源源.钙通道阻滞剂在降压治疗中的应用[J].心血管病学进展,2015,(6):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
　CHEN Yuanyuan.Application of Calcium Channel Blockers in Hypertension Treatment[J].Advances in Cardiovascular Diseases,2015,(11):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
[4]张瑞 毛露 孙硕 Dirk Hermann 陈艾东.内皮素-1干预成为高血压治疗新靶点的展望[J].心血管病学进展,2019,(7):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
　ZHANG Rui MAO LuSUN ShuoDIRK Hermann CHEN Aidong.The Prospect of Endothelin-1 Intervention as A New Target for the Treatment of Hypertension[J].Advances in Cardiovascular Diseases,2019,(11):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
[5]张毅,柳志红.动态血压监测在高血压中的应用现状与问题[J].心血管病学进展,2019,(6):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
　ZHANG Yi,LIU Zhihong.Current status and nsolved Pproblems of Ambulatory Blood Pressure Monitoring for the Management of Hypertension[J].Advances in Cardiovascular Diseases,2019,(11):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
[6]黄秋瑾 胡蓉.高血压合并糖尿病患者血压控制率和控制目标的探讨[J].心血管病学进展,2019,(7):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
　HUANG QiujinHU Rong.Discussion on Blood Pressure Control Rate and Control Target in Patients with Hypertension Complicated with Diabetes[J].Advances in Cardiovascular Diseases,2019,(11):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
[7]张旭明 王曦.高血压对认知功能的影响[J].心血管病学进展,2019,(7):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
　ZHANG Xuming,WANG Xi.The Relationship Between Hypertension and Cognitive Function[J].Advances in Cardiovascular Diseases,2019,(11):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
[8]凌梦军 陈明凌梦军.阻塞性睡眠呼吸暂停低通气综合征与高血压关系的研究进展[J].心血管病学进展,2019,(5):722.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.015]
[9]李波 郭毅 田进文 邓珏琳.高血压合并2型糖尿病的治疗进展[J].心血管病学进展,2019,(9):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
　LI Bo,GUO Yi,TIAN Jinwen,et al.Therapy in Hypertensive Patients with Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(11):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
[10]王继航 赵施皓 李开亮 田进文 李玉龙 付士辉 沈明志 邓珏琳.远程医疗在高血压病管理中的研究进展[J].心血管病学进展,2019,(9):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]
　WANG Jihang,ZHAO Shihao,LI Kailiang,et al.Telemedicine in Hypertension Management[J].Advances in Cardiovascular Diseases,2019,(11):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]

更新日期/Last Update: 2021-02-07